Table 1.
TAC | K1 (ml·cm−3·min−1) | Vb | VT | ||
---|---|---|---|---|---|
R 1 | 0.35 | 1.63 | 0.050 | 8.7 | – |
T 1 | 0.35 | 2.3 | 0.050 | 11 | 0.25 |
T 2 | 0.35 | 1.7 | 0.050 | 8.9 | 0.03 |
T 3 | 0.35 | 2.0 | 0.050 | 9.9 | 0.14 |
T 4 | 0.35 | 2.6 | 0.050 | 12 | 0.37 |
T 5 | 0.35 | 2.9 | 0.050 | 13 | 0.48 |
T 6 | 0.35 | 2.3 | 0.025 | 11 | 0.25 |
T 7 | 0.35 | 2.3 | 0.075 | 11 | 0.25 |
T 8 | 0.21 | 2.3 | 0.050 | 11 | 0.25 |
T 9 | 0.25 | 2.3 | 0.050 | 11 | 0.25 |
T 10 | 0.28 | 2.3 | 0.050 | 11 | 0.25 |
T 11 | 0.32 | 2.3 | 0.050 | 11 | 0.25 |
T 12 | 0.39 | 2.3 | 0.050 | 11 | 0.25 |
T 13 | 0.43 | 2.3 | 0.050 | 11 | 0.25 |
T 14 | 0.46 | 2.3 | 0.050 | 11 | 0.25 |
T 15 | 0.50 | 2.3 | 0.050 | 11 | 0.25 |
K1, k2, and k3 are rate constants, Vb is fractional blood volume, VT is volume of distribution, and and are binding potentials estimated directly (2T4k) and indirectly (2T4ki) using the reversible two-tissue model, respectively. The indirect calculation of BPND was performed using target to reference volumes of distribution ratios. During all simulations, k4 (0.032 min−1) and K1/k2 (3.3) were fixed